Overuse of short-acting β<sub>2</sub>-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme

Bright I. Nwaru(Tampere University), Christer Janson(Uppsala University), Magnus Ekström(Lund University), Gunilla Telg(AstraZeneca (Sweden)), Fredrik Wiklund(Statisticon (Sweden)), Pål Hasvold(AstraZeneca (Sweden))
European Respiratory Journal
January 16, 2020
Cited by 447


Related Papers